Literature DB >> 5641253

Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease.

L Pauling.   

Abstract

The functioning of the brain is affected by the molecular concentrations of many substances that are normally present in the brain. The optimum concentrations of these substances for a person may differ greatly from the concentrations provided by his normal diet and genetic machinery. Biochemical and genetic arguments support the idea that orthomolecular therapy, the provision for the individual person of the optimum concentrations of important normal constituents of the brain, may be the preferred treatment for many mentally ill patients. Mental symptoms of avitaminosis sometimes are observed long before any physical symptoms appear. It is likely that the brain is more sensitive to changes in concentration of vital substances than are other organs and tissues. Moreover, there is the possibility that for some persons the cerebrospinal concentration of a vital substance may be grossly low at the same time that the concentration in the blood and lymph is essentially normal. A physiological abnormality such as decreased permeability of the blood-brain barrier for the vital substance or increased rate of metabolism of the substance in the brain may lead to a cerebral deficiency and to a mental disease. Diseases of this sort may be called localized cerebral deficiency diseases. It is suggested that the genes responsible for abnormalities (deficiencies) in the concentration of vital substances in the brain may be responsible for increased penetrance of the postulated gene for schizophrenia, and that the so-called gene for schizophrenia may itself be a gene that leads to a localized cerebral deficiency in one or more vital substances.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5641253     DOI: 10.1126/science.160.3825.265

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

Review 1.  Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?

Authors:  Roderick H Dashwood; Melinda C Myzak; Emily Ho
Journal:  Carcinogenesis       Date:  2005-11-02       Impact factor: 4.944

2.  The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery.

Authors:  Thomas O Metz; Qibin Zhang; Jason S Page; Yufeng Shen; Stephen J Callister; Jon M Jacobs; Richard D Smith
Journal:  Biomark Med       Date:  2007-06       Impact factor: 2.851

Review 3.  Toxicity of vitamins: complications of a health movement.

Authors:  C D Evans; J H Lacey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

Review 4.  The Topical Evolution: Free Ions, Orthomolecular Agents, Phytochemicals, and Insect-Produced Substances.

Authors:  Teresa Conner-Kerr
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-08-01       Impact factor: 4.730

5.  When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-03

6.  Ascorbic acid: effect of high doses on brain and heart catecholamine levels in guinea-pigs and rats.

Authors:  T Dashman; D Horst; G Bautz; J J Kamm
Journal:  Experientia       Date:  1973

7.  Bioelectronics and cancer.

Authors:  A Szent-Györgyi
Journal:  J Bioenerg       Date:  1973

8.  Iherited abnormalities affecting the nervous system: genetic and psychiatric aspects.

Authors:  J Stern; V Cowie
Journal:  Biochem J       Date:  1969-02       Impact factor: 3.857

9.  Effect of abnormal amino acid concentrations on blood-brain barrier.

Authors:  A D Goldstone; S B Needleman
Journal:  Experientia       Date:  1971-07

Review 10.  Vitamins in psychiatry. Do they have a role?

Authors:  W M Petrie; T A Ban
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.